{"id":"https://openalex.org/W2010793728","doi":"https://doi.org/10.1016/s0968-0896(97)00093-x","title":"Synthesis, structure and quantitative structure-activity relationships of \u03c3 receptor ligands, 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazines","display_name":"Synthesis, structure and quantitative structure-activity relationships of \u03c3 receptor ligands, 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazines","publication_year":1997,"publication_date":"1997-08-01","ids":{"openalex":"https://openalex.org/W2010793728","doi":"https://doi.org/10.1016/s0968-0896(97)00093-x","mag":"2010793728","pmid":"https://pubmed.ncbi.nlm.nih.gov/9313869"},"language":"en","primary_location":{"id":"doi:10.1016/s0968-0896(97)00093-x","doi":"https://doi.org/10.1016/s0968-0896(97)00093-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0968-0896(97)00093-x","pdf_url":null,"source":{"id":"https://openalex.org/S10422866","display_name":"Bioorganic & Medicinal Chemistry","issn_l":"0968-0896","issn":["0968-0896","1464-3391"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075678708","display_name":"Ken\u2010ichi Fujimura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I149737975","display_name":"Santen (Japan)","ror":"https://ror.org/032msy923","country_code":"JP","type":"company","lineage":["https://openalex.org/I149737975"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ken-ichi Fujimura","raw_affiliation_strings":["Developmental Research Division, Santen Pharmaceutical Co., Ltd., Osaka, Japan","Developmental Research Division, Santen Pharmaceutical Co., Ltd, 9-19 Shimoshinjo 3-chome, Higashiyodogawa-ku, Osaka 533, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Developmental Research Division, Santen Pharmaceutical Co., Ltd., Osaka, Japan","institution_ids":["https://openalex.org/I149737975"]},{"raw_affiliation_string":"Developmental Research Division, Santen Pharmaceutical Co., Ltd, 9-19 Shimoshinjo 3-chome, Higashiyodogawa-ku, Osaka 533, Japan","institution_ids":["https://openalex.org/I149737975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110014778","display_name":"Junzo Matsumoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I149737975","display_name":"Santen (Japan)","ror":"https://ror.org/032msy923","country_code":"JP","type":"company","lineage":["https://openalex.org/I149737975"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Junzo Matsumoto","raw_affiliation_strings":["Developmental Research Division, Santen Pharmaceutical Co., Ltd, 9-19 Shimoshinjo 3-chome, Higashiyodogawa-ku, Osaka 533, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Developmental Research Division, Santen Pharmaceutical Co., Ltd, 9-19 Shimoshinjo 3-chome, Higashiyodogawa-ku, Osaka 533, Japan","institution_ids":["https://openalex.org/I149737975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046941354","display_name":"Masashi Niwa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I149737975","display_name":"Santen (Japan)","ror":"https://ror.org/032msy923","country_code":"JP","type":"company","lineage":["https://openalex.org/I149737975"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masashi Niwa","raw_affiliation_strings":["Developmental Research Division, Santen Pharmaceutical Co., Ltd, 9-19 Shimoshinjo 3-chome, Higashiyodogawa-ku, Osaka 533, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Developmental Research Division, Santen Pharmaceutical Co., Ltd, 9-19 Shimoshinjo 3-chome, Higashiyodogawa-ku, Osaka 533, Japan","institution_ids":["https://openalex.org/I149737975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000509868","display_name":"Tadayuki Kobayashi","orcid":"https://orcid.org/0000-0001-7898-0916","observed_orcids":["https://orcid.org/0000-0001-7898-0916"]},"institutions":[{"id":"https://openalex.org/I149737975","display_name":"Santen (Japan)","ror":"https://ror.org/032msy923","country_code":"JP","type":"company","lineage":["https://openalex.org/I149737975"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tadayuki Kobayashi","raw_affiliation_strings":["Developmental Research Division, Santen Pharmaceutical Co., Ltd, 9-19 Shimoshinjo 3-chome, Higashiyodogawa-ku, Osaka 533, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Developmental Research Division, Santen Pharmaceutical Co., Ltd, 9-19 Shimoshinjo 3-chome, Higashiyodogawa-ku, Osaka 533, Japan","institution_ids":["https://openalex.org/I149737975"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yoichi Kawashima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I149737975","display_name":"Santen (Japan)","ror":"https://ror.org/032msy923","country_code":"JP","type":"company","lineage":["https://openalex.org/I149737975"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoichi Kawashima","raw_affiliation_strings":["Product Development Center, Santen Pharmaceutical Co., Ltd, 9-19 Shimoshinjo 3-chome, Higashiyodogawa-ku, Osaka 533, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Product Development Center, Santen Pharmaceutical Co., Ltd, 9-19 Shimoshinjo 3-chome, Higashiyodogawa-ku, Osaka 533, Japan","institution_ids":["https://openalex.org/I149737975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030906776","display_name":"Yasuko In","orcid":"https://orcid.org/0000-0002-0083-5847","observed_orcids":["https://orcid.org/0000-0002-0083-5847"]},"institutions":[{"id":"https://openalex.org/I90237989","display_name":"Osaka University of Pharmaceutical Sciences","ror":"https://ror.org/029yaft79","country_code":"JP","type":"education","lineage":["https://openalex.org/I205143321","https://openalex.org/I90237989"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasuko In","raw_affiliation_strings":["Osaka University of Pharmaceutical Sciences, 20-1 Nasahara 4-chome, Takatsuki, Osaka 569-11, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Osaka University of Pharmaceutical Sciences, 20-1 Nasahara 4-chome, Takatsuki, Osaka 569-11, Japan","institution_ids":["https://openalex.org/I90237989"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102420535","display_name":"Toshimasa Ishida","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I90237989","display_name":"Osaka University of Pharmaceutical Sciences","ror":"https://ror.org/029yaft79","country_code":"JP","type":"education","lineage":["https://openalex.org/I205143321","https://openalex.org/I90237989"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshimasa Ishida","raw_affiliation_strings":["Osaka University of Pharmaceutical Sciences, 20-1 Nasahara 4-chome, Takatsuki, Osaka 569-11, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Osaka University of Pharmaceutical Sciences, 20-1 Nasahara 4-chome, Takatsuki, Osaka 569-11, Japan","institution_ids":["https://openalex.org/I90237989"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3960,"currency":"USD","value_usd":3960},"apc_paid":null,"fwci":1.4348,"has_fulltext":false,"cited_by_count":37,"citation_normalized_percentile":{"value":0.78560568,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"5","issue":"8","first_page":"1675","last_page":"1683"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sigma-receptor-ligands","display_name":"sigma receptor ligands","score":0.9380000233650208},{"id":"https://openalex.org/keywords/sigma-1-receptor","display_name":"sigma-1 receptor","score":0.8190000057220459},{"id":"https://openalex.org/keywords/piperazine","display_name":"piperazine","score":0.7549999952316284},{"id":"https://openalex.org/keywords/sa4503","display_name":"SA4503","score":0.9440000057220459},{"id":"https://openalex.org/keywords/crystal-structure","display_name":"crystal structure","score":0.8939999938011169},{"id":"https://openalex.org/keywords/dihedral-angle","display_name":"dihedral angle","score":0.8730000257492065},{"id":"https://openalex.org/keywords/qsar","display_name":"QSAR","score":0.7400000095367432},{"id":"https://openalex.org/keywords/electronic-effects","display_name":"electronic effects","score":0.31299999356269836}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9678730368614197},{"id":"https://openalex.org/C115624301","wikidata":"https://www.wikidata.org/wiki/Q895901","display_name":"Crystal structure","level":2,"score":0.7284073233604431},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.7104674577713013},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.543334424495697},{"id":"https://openalex.org/C32909587","wikidata":"https://www.wikidata.org/wiki/Q11369","display_name":"Molecule","level":2,"score":0.44684284925460815},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.43256285786628723},{"id":"https://openalex.org/C178910836","wikidata":"https://www.wikidata.org/wiki/Q2196961","display_name":"Molecular model","level":2,"score":0.42074811458587646},{"id":"https://openalex.org/C114373084","wikidata":"https://www.wikidata.org/wiki/Q273499","display_name":"Chemical synthesis","level":3,"score":0.4133000075817108},{"id":"https://openalex.org/C8010536","wikidata":"https://www.wikidata.org/wiki/Q160398","display_name":"Crystallography","level":1,"score":0.29010042548179626},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.1733747124671936},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.09289819002151489},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08806502819061279}],"mesh":[{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006146","descriptor_name":"Guanidines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006146","descriptor_name":"Guanidines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008970","descriptor_name":"Molecular Weight","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010423","descriptor_name":"Pentazocine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010423","descriptor_name":"Pentazocine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017480","descriptor_name":"Receptors, sigma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018360","descriptor_name":"Crystallography, X-Ray","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0968-0896(97)00093-x","doi":"https://doi.org/10.1016/s0968-0896(97)00093-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0968-0896(97)00093-x","pdf_url":null,"source":{"id":"https://openalex.org/S10422866","display_name":"Bioorganic & Medicinal Chemistry","issn_l":"0968-0896","issn":["0968-0896","1464-3391"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:9313869","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9313869","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W330943824","https://openalex.org/W1494840799","https://openalex.org/W1966632536","https://openalex.org/W1971344996","https://openalex.org/W1986484791","https://openalex.org/W2007341344","https://openalex.org/W2020952440","https://openalex.org/W2021583585","https://openalex.org/W2024191422","https://openalex.org/W2030262101","https://openalex.org/W2039902078","https://openalex.org/W2040326898","https://openalex.org/W2046516880","https://openalex.org/W2052214529","https://openalex.org/W2058745429","https://openalex.org/W2059611779","https://openalex.org/W2068049514","https://openalex.org/W2073089890","https://openalex.org/W2073622329","https://openalex.org/W2074900847","https://openalex.org/W2081167192","https://openalex.org/W2088087555","https://openalex.org/W2093367613","https://openalex.org/W2127336290","https://openalex.org/W2155358697","https://openalex.org/W2160538556","https://openalex.org/W2160790360","https://openalex.org/W2241646606","https://openalex.org/W2319749089","https://openalex.org/W2415104265","https://openalex.org/W2943705922","https://openalex.org/W2953094740"],"related_works":["https://openalex.org/W2070194801","https://openalex.org/W2015524948","https://openalex.org/W2056693874","https://openalex.org/W2003715023","https://openalex.org/W1999149222","https://openalex.org/W2091226112","https://openalex.org/W2507493489","https://openalex.org/W1985396940","https://openalex.org/W2166508411","https://openalex.org/W2027502162"],"abstract_inverted_index":null,"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}